Park 2018.
Study characteristics | |||
Patient Sampling | Method of sampling: selected Included conditions: unclear Teeth: permanent incisors (25), premolars (11) and molars (15) Sealants: not reported Restorations: not reported Surface: smooth |
||
Patient characteristics and setting | Age: not reported Sex: not reported Ethnicity: not reported Country: Germany Setting: extracted teeth Number of participants/teeth/sites: 51 teeth, 133 sites Prevalence: enamel 0.73, dentine 0.05 |
||
Index tests | Category of test: spectral domain OCT Sequence of test(s): ordering of tests not clear Examiner training and calibration: examiner was an experienced user of OCT Threshold applied: ICDAS 0‐4 was applied to OCT Device specifics: Telesto II (Thorlabs GmbH, Dachau, Germany); "Technical specifications of the SD‐OCT system were as follows: center wavelength 1310 nm ± 107 nm, sensitivity ≤ 106 dB, axial/lateral resolution < 7.5 (air)/15 μm, field of view ≤ 10 mm × 10 mm × 3.5 mm (pixel size 700 × 700 × 512), imaging speed 48–91 kHz, and A‐scan average 1–5" |
||
Target condition and reference standard(s) | Category: visual Sequence of index test and reference standard: unclear ordering of tests Training of examiner: not reported Blinding to index test: unclear Multiple tests: no Site selection: specified regions of interest Target condition: ICDAS 0‐4 |
||
Flow and timing | Participants with index test but no reference standard: 0 Participants with reference standard but no index test: 0 Time interval between tests: minimal Participants receiving both tests but excluded from results: 0 |
||
Comparative | |||
Notes | 3 studies in this paper that could have been included. The first was in vitro, OCT (swept source) versus histology, could not be included as no data were presented. The second, in vitro part (OCT ‐ spectral domain) is included, above. The third in vivo element (OCT ‐ spectral domain) but samples participants with caries up to ICDAS 4, so we had to exclude this study | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | No | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | High | ||
DOMAIN 2: Index Test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | Yes | ||
If multiple tests were applied were different examiners used for each (in vivo)? | |||
Could the conduct or interpretation of the index test have introduced bias? | Unclear risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | No | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | High risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | Low risk |